162 related articles for article (PubMed ID: 12640217)
1. Clinical and neurobiological effects of tianeptine and paroxetine in major depression.
Nickel T; Sonntag A; Schill J; Zobel AW; Ackl N; Brunnauer A; Murck H; Ising M; Yassouridis A; Steiger A; Zihl J; Holsboer F
J Clin Psychopharmacol; 2003 Apr; 23(2):155-68. PubMed ID: 12640217
[TBL] [Abstract][Full Text] [Related]
2. The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder.
Schruers K; Griez E
J Psychopharmacol; 2004 Dec; 18(4):553-8. PubMed ID: 15582922
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine.
Waintraub L; Septien L; Azoulay P
CNS Drugs; 2002; 16(1):65-75. PubMed ID: 11772119
[TBL] [Abstract][Full Text] [Related]
4. Baseline lipid levels and acute treatment response to paroxetine and tianeptine in depressed women.
Mück-Seler D; Sagud M; Mihaljevi-Peles A; Jakovljevi M; Pivac N
J Clin Psychopharmacol; 2011 Jun; 31(3):387-90. PubMed ID: 21532370
[No Abstract] [Full Text] [Related]
5. Tianeptine: a review of its use in depressive disorders.
Wagstaff AJ; Ormrod D; Spencer CM
CNS Drugs; 2001; 15(3):231-59. PubMed ID: 11463130
[TBL] [Abstract][Full Text] [Related]
6. State markers of depression in sleep EEG: dependency on drug and gender in patients treated with tianeptine or paroxetine.
Murck H; Nickel T; Künzel H; Antonijevic IA; Schill J; Zobel A; Steiger A; Sonntag A; Holsboer F
Neuropsychopharmacology; 2003 Feb; 28(2):348-58. PubMed ID: 12589388
[TBL] [Abstract][Full Text] [Related]
7. The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression.
Mück-Seler D; Pivac N; Sagud M; Jakovljević M; Mihaljević-Peles A
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Dec; 26(7-8):1235-43. PubMed ID: 12502009
[TBL] [Abstract][Full Text] [Related]
8. [A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression].
Olié JP; Baylé F; Kasper S
Encephale; 2003; 29(4 Pt 1):322-8. PubMed ID: 14615702
[TBL] [Abstract][Full Text] [Related]
9. Tianeptine therapy for depression in the elderly.
Saiz-Ruiz J; Montes JM; Alvarez E; Cervera S; Giner J; Guerrero J; Seva A; Dourdil F; López-Ibor JJ
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Feb; 22(2):319-29. PubMed ID: 9608604
[TBL] [Abstract][Full Text] [Related]
10. Tianeptine and fluoxetine in major depression: a 6-week randomised double-blind study.
Novotny V; Faltus F
Hum Psychopharmacol; 2002 Aug; 17(6):299-303. PubMed ID: 12404675
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine.
Lôo H; Saiz-Ruiz J; Costa e Silva JACE ; Ansseau M; Herrington R; Vaz-Serra A; Dilling H; de Risio S
J Affect Disord; 1999 Dec; 56(2-3):109-18. PubMed ID: 10701468
[TBL] [Abstract][Full Text] [Related]
12. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
[TBL] [Abstract][Full Text] [Related]
13. Improvement in subjective and objective neurocognitive functions in patients with major depressive disorder: a 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study.
Jeon HJ; Woo JM; Lee SH; Kim EJ; Chung S; Ha JH; Fava M; Mischoulon D; Kim JH; Heo JY; Yu BH
J Clin Psychopharmacol; 2014 Apr; 34(2):218-25. PubMed ID: 24525660
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression.
Kasper S; Olié JP
Eur Psychiatry; 2002 Jul; 17 Suppl 3():331-40. PubMed ID: 15177089
[TBL] [Abstract][Full Text] [Related]
15. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
[TBL] [Abstract][Full Text] [Related]
16. Tianeptine in the combined treatment of combat related posttraumatic stress disorder.
Frančišković T; Suković Z; Janović S; Stevanović A; Nemčić-Moro I; Rončević-Gržeta I; Letica-Crepulja M
Psychiatr Danub; 2011 Sep; 23(3):257-63. PubMed ID: 21963693
[TBL] [Abstract][Full Text] [Related]
17. Paroxetine augmentation to tianeptine treatment causes exacerbation of depressive symptoms: presentation of two cases.
Oztürk O; Eraslan D; Kayahan B
Int J Psychiatry Clin Pract; 2004; 8(4):262-4. PubMed ID: 24930557
[TBL] [Abstract][Full Text] [Related]
18. Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms: A prospective double-blind study in depressed elderly patients.
Mamo DC; Sweet RA; Mulsant BH; Pollock BG; Miller MD; Stack JA; Begley AE; Reynolds CF
Am J Geriatr Psychiatry; 2000; 8(3):226-31. PubMed ID: 10910421
[TBL] [Abstract][Full Text] [Related]
19. Triiodothyronine addition to paroxetine in the treatment of major depressive disorder.
Appelhof BC; Brouwer JP; van Dyck R; Fliers E; Hoogendijk WJ; Huyser J; Schene AH; Tijssen JG; Wiersinga WM
J Clin Endocrinol Metab; 2004 Dec; 89(12):6271-6. PubMed ID: 15579788
[TBL] [Abstract][Full Text] [Related]
20. Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline.
Pezzella G; Moslinger-Gehmayr R; Contu A
Breast Cancer Res Treat; 2001 Nov; 70(1):1-10. PubMed ID: 11766999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
